- Animal and human vaccines are increasingly vital tools in the Middle East and Africa for preventing infectious diseases and improving public health outcomes across both human populations and livestock, especially in regions vulnerable to zoonotic diseases and endemic infections
- The rising demand for vaccines in the region is largely driven by increased awareness of immunization programs, government and WHO-backed vaccination initiatives, and growing investments in veterinary healthcare and livestock management
- Saudi Arabia dominated the Middle East and Africa animal and human vaccines market with the largest revenue share of 28.3% in 2024, due to strong national immunization campaigns, advanced healthcare infrastructure, and increasing adoption of modern veterinary practices aimed at improving food security and public health
- U.A.E. is expected to be the fastest-growing country in the Middle East and Africa animal and human vaccines market during the forecast period, fueled by rapid urbanization, rising pet ownership, supportive regulatory frameworks, and private sector involvement in human and animal vaccine R&D
- Human segment dominated the Middle East and Africa animal and human vaccines market with a market share of 61.3% in 2024, driven by widespread government-led immunization programs, increasing healthcare expenditure, and growing awareness about vaccine-preventable diseases. Initiatives by organizations such as WHO and GAVI have further strengthened access to life-saving vaccines for populations across the region
